Schedule 13G ownership disclosure
ARRAY BIOPHARMA INC
Security class unavailable · CUSIP: 04269X105
Event date: 2014-05-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,142,022
- Percent of class
- 8.6900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001425738-15-000006
- Form type
- SC 13G
- Filer
- ARRAY BIOPHARMA INC
- CIK
- CIK 1100412
- Filed
- Feb 18, 2015
- Reporting period
- May 16, 2014
- Description
- Schedule 13G beneficial ownership